
Sign up to save your podcasts
Or
Digital health, a new LDL-c lowering drug, PCSK9i outcomes in higher risk patients, and an ESC preview are discussed by John Mandrola in this week’s podcast.
4.9
838838 ratings
Digital health, a new LDL-c lowering drug, PCSK9i outcomes in higher risk patients, and an ESC preview are discussed by John Mandrola in this week’s podcast.
135 Listeners
13 Listeners
315 Listeners
171 Listeners
497 Listeners
31 Listeners
18 Listeners
278 Listeners
3,316 Listeners
137 Listeners
1,103 Listeners
58 Listeners
195 Listeners
518 Listeners
350 Listeners
60 Listeners
25 Listeners
8 Listeners
428 Listeners
365 Listeners